Issued Patents All Time
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11970479 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | John J. Acton, III, Melissa Egbertson, Xiaolei Gao, Scott T. Harrison, Timothy J. Henderson +11 more | 2024-04-30 |
| 11655216 | Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, compositions, and their use | Michael T. Rudd, Jenny Wai, David Jonathan Bennett, Edward J. Brnardic, Nigel J. Liverton +6 more | 2023-05-23 |
| 11149036 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | John J. Acton, III, Jianming Bao, Qiaolin Deng, Melissa Egbertson, Ronald D. Ferguson +12 more | 2021-10-19 |
| 10961215 | N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use | Michael T. Rudd, Jenny Wai, David Jonathan Bennett, Edward J. Brnardic, Nigel J. Liverton +5 more | 2021-03-30 |
| 10933056 | 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor | John J. Acton, III, Jianming Bao, Melissa Egbertson, Xiaolei Gao, Scott T. Harrison +9 more | 2021-03-02 |
| 10894775 | Piperidine derivatives as liver X receptor beta agonists, compositions, and their use | Michael T. Rudd, Jenny Wai, David Jonathan Bennett, Edward J. Brnardic, Nigel J. Liverton +7 more | 2021-01-19 |
| 10752587 | Homobispiperidinyl derivatives as liver X receptor beta agonists, compositions and their use | Michael T. Rudd, David Jonathan Bennett, Jenny Wai | 2020-08-25 |
| 9663506 | Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use | Christopher James Bungard, Antonella Converso, Pablo de Leon, Barbara Hanney, Timothy J. Hartingh +6 more | 2017-05-30 |
| 9636337 | Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use | Christopher James Bungard, Antonella Converso, Pablo de Leon, Barbara Hanney, Timothy J. Hartingh +6 more | 2017-05-02 |
| 9227971 | Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors | M. Arshad Siddiqui, Yang Nan, Mehul Patel, Panduranga Adulla P. Reddy, Umar Faruk Mansoor +12 more | 2016-01-05 |
| 8927562 | Fused tricyclic inhibitors of mammalian target of rapamycin | Panduranga Adulla P. Reddy, M. Arshad Siddiqui | 2015-01-06 |
| 8901142 | Fused tricyclic compounds as mTOR inhibitors | M. Arshad Siddiqui, Panduranga Adulla P. Reddy, Mehul Patel, Yang Nan | 2014-12-02 |
| 8703784 | Substituted pyrazolo[1,5-a]pyrido[3.2-e]pyrimidin-6-one inhibitors of mammalian target of rapamycin | Panduranga Adulla P. Reddy, M. Arshad Siddiqui, Amit K. Mandal, Duan Liu, Lianyun Zhao +1 more | 2014-04-22 |
| 8609675 | Fused Tricyclic Compounds as novel mTOR inhibitors | Cliff C. Cheng, Hongbo Zeng, Gerald W. Shipps, Jr., Yongqi Deng, Lianyun Zhao +5 more | 2013-12-17 |
| 8591943 | Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitors | Yongqi Deng, Binyuan Sun, Hongbo Zeng, Matthew Richards, Gerald W. Shipps, Jr. +13 more | 2013-11-26 |